Need a Chief Medical Officer – just not full time?
Many biotech companies reach a point where senior medical leadership is essential, but the timing for a permanent C-suite hire isn’t right. A fractional Chief Medical Officer (CMO) bridges that gap and offers:
- Senior leadership without fixed overheads
- Flexibility to scale support as your programme evolves
- Protection if timelines shift due to preclinical or toxicology delays
What is a tranScrip fractional CMO?
Our fractional CMOs are experienced, CMO-level medical leaders provided on a flexible basis, without the cost or commitment of a full-time hire. They act as an accountable medical leader and thought partner in your drug discovery and early development programme.
What does a fractional CMO do?
A fractional CMO leads and integrates early development strategy, including:
- Refining the Target Product Profile
- Building translational and biomarker strategies
- Conducting indication evaluation
- Writing and owning the clinical development plan
Their role is to bring clarity and senior oversight to decisions that drive programme and company value.
How do they support early-stage development?
Fractional CMOs support first-time-in-human and proof-of-concept studies, helping to:
- Integrate PK/PD modelling
- Define safety windows
- Support vendor and CRO selection
This enables faster, better-informed decisions – without junior bottlenecks or disconnected consultants.
Do they work beyond clinical execution?
Yes. Drug development doesn’t happen in isolation.
A fractional CMO engages with key opinion leaders, patient groups, regulators, and payers, ensuring your strategy is externally credible and aligned for long-term success.
What makes tranScrip’s fractional CMO different?
Our fractional CMOs are backed by a full multidisciplinary team, providing one accountable medical leader supported by experts across development, regulatory, and strategy.
What’s the result?
Clear leadership, faster decisions, and confidence that every critical step is guided by people who have done it before.
If you’re approaching candidate selection or early clinical development, speak with tranScrip to understand how our fractional Chief Medical Officer service can help you close the CMO gap.